Matches in Wikidata for { <http://www.wikidata.org/entity/Q63398046> ?p ?o ?g. }
Showing items 1 to 28 of
28
with 100 items per page.
- Q63398046 description "clinical trial" @default.
- Q63398046 description "ensayu clínicu" @default.
- Q63398046 description "klinisch onderzoek" @default.
- Q63398046 description "клінічне випробування" @default.
- Q63398046 name "A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule" @default.
- Q63398046 type Item @default.
- Q63398046 label "A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule" @default.
- Q63398046 prefLabel "A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule" @default.
- Q63398046 P1132 Q63398046-E6EAD7D2-14FD-4F22-A910-CCB0136ACC2A @default.
- Q63398046 P1476 Q63398046-6FD7D84E-0829-424F-8E20-FCF6B6E18215 @default.
- Q63398046 P17 Q63398046-86E3B82F-F3F5-4225-813D-615E74ABF886 @default.
- Q63398046 P3098 Q63398046-111430EC-5489-4D8F-A15E-4A60BDABCD15 @default.
- Q63398046 P31 Q63398046-7D08044C-F432-4B71-85C8-5113E4CE0F40 @default.
- Q63398046 P580 Q63398046-3CEE1E37-20AB-4899-87B4-7632C20F1C6D @default.
- Q63398046 P582 Q63398046-0E9510E4-FB65-47F5-A0B6-4FAE970272A6 @default.
- Q63398046 P6099 Q63398046-D7115AD1-8D55-40B4-A7F5-9AE0AABECD30 @default.
- Q63398046 P6153 Q63398046-B9A0D70B-6B63-48FB-AF53-D93D3A2D9295 @default.
- Q63398046 P8363 Q63398046-58ECD78E-A9D5-4472-9CE4-D29BD86FA656 @default.
- Q63398046 P1132 "+302" @default.
- Q63398046 P1476 "A Phase 2, Observer-blind, Active-controlled, Randomized Dose-finding Study in Healthy Infants to Assess the Safety, Reactogenicity and Immunogenicity of 3 Dose Levels of a Trivalent Inactivated Poliovirus Vaccine Based on Sabin Strains Compared to Conventional Salk IPV, in a 6, 10 and 14 Weeks of Age Immunization Schedule, and Co-administered With Diphtheria, Tetanus, Whole Cell Pertussis, Haemophilus Influenzae Type b, Hepatitis B, Pneumococcal Conjugate and Rotavirus Vaccines" @default.
- Q63398046 P17 Q928 @default.
- Q63398046 P3098 "NCT03566940" @default.
- Q63398046 P31 Q30612 @default.
- Q63398046 P580 "2018-07-31T00:00:00Z" @default.
- Q63398046 P582 "2019-07-18T00:00:00Z" @default.
- Q63398046 P6099 Q42824440 @default.
- Q63398046 P6153 Q775409 @default.
- Q63398046 P8363 Q78089383 @default.